Biotech-2023
Asset Allocation
| Position | Category/Sector | Weight |
|---|---|---|
ISRG Intuitive Surgical, Inc. | Healthcare | 33% |
ARWR Arrowhead Pharmaceuticals, Inc. | Healthcare | 20% |
SAGE Sage Therapeutics, Inc. | Healthcare | 14% |
TGTX TG Therapeutics, Inc. | Healthcare | 9% |
MREO Mereo BioPharma Group plc | Healthcare | 9% |
NTLA Intellia Therapeutics, Inc. | Healthcare | 9% |
ONCT Oncternal Therapeutics, Inc. | Healthcare | 4% |
DTIL Precision BioSciences, Inc. | Healthcare | 2% |
Performance
The chart shows the growth of an initial investment of $10,000 in Biotech-2023, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Quarterly
Returns
| 1 month | 6 months | Year-To-Date | 1 year | 5 years (annualized) | 10 years (annualized) | |
|---|---|---|---|---|---|---|
| Benchmark | -1.29% | 8.79% | 12.52% | 16.97% | 9.22% | N/A |
| Biotech-2023 | -3.46% | -3.31% | -7.95% | 16.42% | 8.26% | N/A |
| Portfolio components: | ||||||
ARWR Arrowhead Pharmaceuticals, Inc. | -2.85% | 12.14% | -32.84% | -11.93% | 8.58% | N/A |
SAGE Sage Therapeutics, Inc. | -1.06% | -54.42% | -48.72% | -49.19% | -38.28% | N/A |
TGTX TG Therapeutics, Inc. | -11.78% | -37.82% | -22.74% | 59.23% | 2.98% | N/A |
MREO Mereo BioPharma Group plc | -3.57% | 71.21% | 80.00% | 60.39% | -29.97% | N/A |
ONCT Oncternal Therapeutics, Inc. | -8.97% | -64.46% | -68.96% | -62.48% | -52.09% | N/A |
NTLA Intellia Therapeutics, Inc. | -13.67% | -15.43% | -7.17% | -39.93% | 16.23% | N/A |
DTIL Precision BioSciences, Inc. | -23.92% | -45.66% | -68.03% | -68.82% | -54.91% | N/A |
ISRG Intuitive Surgical, Inc. | 0.90% | 12.39% | 8.61% | 51.27% | 12.80% | N/A |
| Returns over 1 year are annualized | ||||||
Asset Correlations Table
| MREO | ONCT | ISRG | DTIL | SAGE | TGTX | ARWR | NTLA | |
|---|---|---|---|---|---|---|---|---|
| MREO | 1.00 | 0.20 | 0.19 | 0.22 | 0.25 | 0.24 | 0.29 | 0.26 |
| ONCT | 0.20 | 1.00 | 0.19 | 0.26 | 0.29 | 0.26 | 0.28 | 0.25 |
| ISRG | 0.19 | 0.19 | 1.00 | 0.31 | 0.36 | 0.42 | 0.40 | 0.44 |
| DTIL | 0.22 | 0.26 | 0.31 | 1.00 | 0.41 | 0.41 | 0.41 | 0.49 |
| SAGE | 0.25 | 0.29 | 0.36 | 0.41 | 1.00 | 0.47 | 0.47 | 0.47 |
| TGTX | 0.24 | 0.26 | 0.42 | 0.41 | 0.47 | 1.00 | 0.52 | 0.55 |
| ARWR | 0.29 | 0.28 | 0.40 | 0.41 | 0.47 | 0.52 | 1.00 | 0.53 |
| NTLA | 0.26 | 0.25 | 0.44 | 0.49 | 0.47 | 0.55 | 0.53 | 1.00 |
Dividend yield
Expense Ratio
The Biotech-2023 has an expense ratio of 0.00%, indicating no management fees are charged. Below you can find the expense ratios of portfolio funds side-by-side and effortlessly compare their relative costs.
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ARWR Arrowhead Pharmaceuticals, Inc. | -0.27 | ||||
SAGE Sage Therapeutics, Inc. | -0.69 | ||||
TGTX TG Therapeutics, Inc. | 0.33 | ||||
MREO Mereo BioPharma Group plc | 0.42 | ||||
ONCT Oncternal Therapeutics, Inc. | -0.63 | ||||
NTLA Intellia Therapeutics, Inc. | -0.82 | ||||
DTIL Precision BioSciences, Inc. | -0.97 | ||||
ISRG Intuitive Surgical, Inc. | 1.46 |
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Biotech-2023. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Biotech-2023 is 62.53%, recorded on May 11, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.53% | Jul 2, 2021 | 217 | May 11, 2022 | — | — | — |
| -51.27% | Dec 2, 2019 | 74 | Mar 18, 2020 | 84 | Jul 17, 2020 | 158 |
| -18.21% | Jan 15, 2021 | 35 | Mar 8, 2021 | 67 | Jun 11, 2021 | 102 |
| -15.2% | Aug 22, 2019 | 29 | Oct 2, 2019 | 22 | Nov 1, 2019 | 51 |
| -9.51% | Sep 3, 2020 | 3 | Sep 8, 2020 | 6 | Sep 16, 2020 | 9 |
Volatility Chart
The current Biotech-2023 volatility is 6.56%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.